Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease (Q42525075)

1 November 2017

title

Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease (English)

1 reference

1 November 2017

0 references

1 reference

9

Ruth Luthi-Carter

1 reference

1 November 2017

2

David W Miller

1 reference

1 November 2017

Boris S Spektor

1

1 reference

1 November 2017

Zane R Hollingsworth

3

1 reference

1 November 2017

Yoshio A Kaneko

4

1 reference

1 November 2017

Steven M Solano

5

1 reference

1 November 2017

Jennifer M Johnson

6

1 reference

1 November 2017

John B Penney

7

1 reference

1 November 2017

Anne B Young

8

1 reference

1 November 2017

publication date

1 June 2002

1 reference

1 November 2017

published in

Molecular Brain Research

1 reference

1 November 2017

volume

102

1 reference

1 November 2017

issue

1-2

1 reference

1 November 2017

page(s)

118-128

1 reference

Examination of the involvement of protein kinase A in D2 dopamine receptor antagonist-induced immediate early gene expression

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Striatal neurochemical changes in transgenic models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

A complex program of striatal gene expression induced by dopaminergic stimulation.

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Transcriptional dysregulation in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Silencing of the constitutive activity of the dopamine D1B receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

D1 dopamine receptor activation of multiple transcription factor genes in rat striatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Molecular effects of dopamine on striatal-projection pathways

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum.

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

A Golgi study of the human neostriatum: neurons and afferent fibers

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Scopolamine attenuates haloperidol-induced c-fos expression in the striatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Characterization and localization of the Huntington disease gene product

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Forskolin and dopamine D1 receptor activation increase huntingtin's association with endosomes in immortalized neuronal cells of striatal origin.

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Amphetamine regulates gene expression in rat striatum via transcription factor CREB.

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Dopamine receptor supersensitivity

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Heterogeneous tissue-specific transcription of dopamine receptor subtype messenger RNA in rat brain

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

The dopamine D1 receptor antagonist SCH-23390 decreases the mRNA levels of the transcription factor zif268 (krox-24) in adult rat intact striatum--an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Dopamine receptor 'supersensitivity' occurring without receptor up-regulation

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

MK-801 reverses Fos expression induced by the full dopamine D1 receptor agonist SKF-82958 in the rat striatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Differential loss of striatal projection neurons in Huntington disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA)

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

High basal expression of the zif/268 immediate early gene in cortical layers IV and VI, in CA1 and in the corpus striatum--an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

The regulation and function of c-fos and other immediate early genes in the nervous system

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

NGFI-B, c-fos, and c-jun mRNA Expression in Mouse Brain After Acute Carbon Monoxide Intoxication

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Induction of immediate early genes by cyclic AMP in primary cultures of neurons from rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Differential induction of immediate early genes by excitatory amino acid receptor types in primary cultures of cortical and striatal neurons

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

1 reference

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Scopolamine augments c-fos and zip/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

Mutant huntingtin enhances excitotoxic cell death.

1 reference

https://api.crossref.org/works/10.1016/S0169-328X(02)00216-4

7 January 2021

10.1016/S0169-328X(02)00216-4

Identifiers

DOI

1 reference

1 November 2017

1 reference